GNH USA

Europe — EMA

Imdur

GNH USA supplies Imdur (Isosorbide 5‑Mononitrate), a nitrate anti‑anginal for prophylaxis of angina pectoris. Request a quote for global supply.

Isosorbide 5 Mononitrate

Request sourcing

1
Pack/s

What is Isosorbide 5 Mononitrate?

Isosorbide 5‑mononitrate, the active ingredient in Imdur, is a nitrate class medication presented as an extended‑release tablet for oral administration. It is indicated for the prophylactic treatment of angina pectoris, helping to reduce the frequency of chest pain episodes in patients with documented coronary artery disease.

GNH USA supplies Imdur as a licensed, Good Distribution Practice‑compliant pharmaceutical product, providing reliable access to hospitals, pharmacies and clinics worldwide through its international supply network. The product complies with EU regulatory standards and is manufactured under strict quality controls.

What is Isosorbide 5 Mononitrate used for?

Imdur (isosorbide 5‑mononitrate) is an anti‑anginal nitrate used in the management of coronary artery disease.

- Stable angina: reduces the frequency of chest pain episodes. - Exercise‑induced angina: improves tolerance to physical activity. - Chronic coronary syndrome: helps prevent myocardial ischemia during daily activities.

What are the side effects of Isosorbide 5 Mononitrate?

Imdur is generally well tolerated, but several adverse reactions have been reported.

Common Side Effects: - Headache: mild to moderate, often transient. - Flushing: warmth and redness of the skin. - Dizziness or light‑headedness. - Hypotension: especially when standing. - Nausea or abdominal discomfort. - Palpitations or tachycardia.

Serious or Rare Side Effects: - Severe hypotension leading to syncope. - Allergic reactions such as rash, itching, or angioedema. - Methemoglobinemia: rare but potentially serious. - Chest pain worsening on abrupt discontinuation. - Life‑threatening hypotensive crisis when combined with other vasodilators.

What precautions apply to Isosorbide 5 Mononitrate?

Before prescribing Imdur, clinicians should consider several safety aspects.

- Abrupt discontinuation: may precipitate rebound angina; tapering is recommended. - Monitor blood pressure: risk of symptomatic hypotension, especially in the elderly. - Hepatic impairment: use with caution in severe liver disease. - Concomitant PDE‑5 inhibitors: avoid due to risk of profound hypotension. - Pregnancy and lactation: safety not established; use only if benefit outweighs potential risk. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

What does Isosorbide 5 Mononitrate interact with?

Imdur can interact with several drug classes, requiring attention to dosing and monitoring.

Major Interactions (Avoid): - Phosphodiesterase‑5 inhibitors (e.g., sildenafil): may cause severe hypotension. - Other nitrates (e.g., nitroglycerin, isosorbide dinitrate): additive vasodilatory effect. - Alcohol: can enhance hypotensive response.

Moderate Interactions (Monitor Closely): - Antihypertensives (ACE inhibitors, beta‑blockers): may increase blood pressure‑lowering effect. - Diuretics: may potentiate orthostatic hypotension. - Azole antifungals (e.g., ketoconazole): may raise plasma levels of isosorbide 5‑mononitrate.

Frequently asked questions

What is Imdur used for?+
Imdur contains isosorbide 5‑mononitrate and is prescribed to prevent episodes of angina pectoris in patients with coronary artery disease. It helps reduce the frequency and severity of chest pain by improving blood flow to the heart muscle.
How does isosorbide 5‑mononitrate work?+
Isosorbide 5‑mononitrate is converted in the body to nitric oxide, a potent vasodilator. Nitric oxide relaxes vascular smooth muscle, leading to dilation of arteries and veins, which lowers cardiac preload and afterload and decreases the heart’s oxygen demand.
What is the usual dose of Imdur?+
The specific dose and dosing schedule of Imdur are determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and other medications. Patients should follow the prescriber’s instructions and not adjust the dose on their own.
Is Imdur safe during pregnancy or breastfeeding?+
Safety data for isosorbide 5‑mononitrate in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.
How do I order Imdur from GNH USA?+
To request Imdur, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.
How does Imdur compare with other anti‑anginal drugs?+
Imdur belongs to the nitrate class, which primarily provides vasodilation. Compared with beta‑blockers or calcium‑channel blockers, nitrates act directly on vascular smooth muscle and are often used when other agents are insufficient or contraindicated. Choice of therapy depends on patient-specific factors and physician judgment.
What are the storage requirements for Imdur?+
Imdur tablets should be stored at ambient temperature, below 25 °C, in the original container. Protect them from moisture, excessive heat, and direct sunlight to maintain product stability throughout its shelf life.
How is Imdur administered?+
Imdur is taken orally as an extended‑release tablet. It is usually swallowed whole with water, and the dosing interval is set by the prescriber, often once daily. Patients should not crush, chew, or split the tablet, as this can alter drug release.
What are the most serious risks associated with Imdur?+
Serious risks include severe hypotension, syncope, and rare allergic reactions such as angioedema. Patients should seek immediate medical attention if they experience fainting, a sudden drop in blood pressure, or signs of a severe allergic response.
Who should not use Imdur?+
Imdur should be avoided in patients with known hypersensitivity to isosorbide 5‑mononitrate or other nitrates, those who have taken phosphodiesterase‑5 inhibitors within 24 hours, and individuals with severe hypotension or certain cardiovascular conditions where vasodilation is contraindicated.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Isosorbide 5 Mononitrate
Route
Oral Use
Manufacturer
Topridge Pharma (Ireland) Limited
Origin
EU

Related products